Vaiva G, Thomas P, Leroux J M, Cottencin O, Dutoit D, Erb F, Goudemand M
Service de Psychiatrie Générale, USN B, CHRU de Lille.
Therapie. 1994 Jul-Aug;49(4):343-8.
Dysregulation of free radical metabolism has been supposed to be involved in schizophrenia etiopathogeny. Recently, Wang et al. showed a red blood cell super oxide dismutase increase in positive schizophrenia (Crow's type I), but neither in negative schizophrenia (Crow's type II) nor in controls. The study included 28 in-patients suffering from acute positive psychosis who were compared with 15 controls. We confirmed the results of Wang. We found a significantly red blood cell Super oxide dismutase increase in positive psychosis, in comparison to negative psychosis and controls (p = 0.0001). This SOD increase was in relationship with the degree of clinical psychomotor excitement. After 21 days of neuroleptic treatment, SOD activity decreased and reached standard values. These results support the hypothesis of striking relationships between catecholaminergic hyper-metabolism and SOD increase, in positive psychosis. These could account for psychotic positive symptoms improvement with neuroleptic treatment, which blocks dopamine pathways.
自由基代谢失调被认为与精神分裂症的病因有关。最近,Wang等人发现,阳性精神分裂症(Crow I型)患者的红细胞超氧化物歧化酶增加,但阴性精神分裂症(Crow II型)患者和对照组均未出现这种情况。该研究纳入了28例患有急性阳性精神病的住院患者,并与15名对照组进行比较。我们证实了Wang的研究结果。我们发现,与阴性精神病患者和对照组相比,阳性精神病患者的红细胞超氧化物歧化酶显著增加(p = 0.0001)。这种超氧化物歧化酶的增加与临床精神运动性兴奋程度有关。经过21天的抗精神病药物治疗后,超氧化物歧化酶活性下降并达到标准值。这些结果支持了阳性精神病中儿茶酚胺能代谢亢进与超氧化物歧化酶增加之间存在显著关系的假说。这可以解释抗精神病药物治疗改善精神病阳性症状的原因,因为抗精神病药物会阻断多巴胺通路。